Alexander Shoushtari
Associate Attending Physician · New York Presbyterian Hospital
Credentials: · · · · ·
History
Research
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
Nature Medicine · 2017 · 2,750 citations
OncoKB: A Precision Oncology Knowledge Base
JCO Precision Oncology · 2017 · 2,318 citations
41 papers
- RC
34 papers
29 papers
26 papers
26 papers
- CB
21 papers
20 papers · 3 as a fellow
- JF
20 papers · 1 as a resident
Clinical trials
- 2022–2027
A Study of LN-144 in People With Metastatic Melanoma to the Brain
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
- 2022–2027
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
- 2022–2027
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2019–2023
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center